No Data
No Data
EU Grants Marketing Authorization For KOSTAIVE To CSL And Arcturus Therapeutics
Arcturus Therapeutics Says EU Commission Approves COVID-19 Vaccine Kostaive
Express News | European Commission Approves CSL and Arcturus Therapeutics’ Kostaive®, the First Self-Amplifying Mrna Covid-19 Vaccine
Shareholders in Arcturus Therapeutics Holdings (NASDAQ:ARCT) Have Lost 59%, as Stock Drops 12% This Past Week
Express News | Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.d., as Chair Designate
Meiji Seika Pharma Secures Approval For Domestic Manufacturing Of KOSTAIVE, Japan's First Self-Amplifying MRNA COVID-19 Vaccine